COUP-TFII is a major regulator of cell cycle and notch signaling pathways

Molecular Endocrinology

Volumn 26, Issue 8, 2012, Pages 1268-1277

  Chen, Xinpu ^a   Qin, Jun ^a   Cheng, Chiang Min ^a   Tsai, Ming Jer ^a   Tsai, Sophia Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; EPHRIN RECEPTOR B4; NOTCH RECEPTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR FOXC1;

ARTICLE; BINDING SITE; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BINDING SITES; CELL CYCLE; CELL CYCLE PROTEINS; CHROMATIN IMMUNOPRECIPITATION; COUP TRANSCRIPTION FACTOR II; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, NOTCH; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VEINS;

EID: 84864440072     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2011-1305     Document Type: Article

References (49)

1. Pereira FA, Qiu Y, Zhou G, Tsai MJ, Tsai SY 1999 The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev 13:1037-1049
2. Qin J, Chen X, Xie X, Tsai MJ, Tsai SY 2010 COUP-TFII regulates tumor growth and metastasis by modulating tumor angiogenesis. Proc Natl Acad Sci USA 107:3687-3692
3. Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY 2010 Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling. Cancer Res 70:8812-8821
4. Ferrara N, Gerber HP, LeCouter J 2003 The biology of VEGF and its receptors. Nat Med 9:669-676
5. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ 1995 Defective haematopoiesis and vasculogenesis in transforming growth factor1 knock out mice. Development 121: 1845-1854
6. Adams RH, Alitalo K 2007 Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 8:464-478
7. Hamada K, Sasaki T, Koni PA, Natsui M, Kishimoto H, Sasaki J, Yajima N, Horie Y, Hasegawa G, Naito M, Miyazaki J, Suda T, Itoh H, Nakao K, Mak TW, Nakano T, Suzuki A 2005 The PTEN/ PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 19:2054-2065
8. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD 1996 Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
9. Fischer C, Mazzone M, Jonckx B, Carmeliet P 2008 FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8:942-956
10. Cao Y 2009 Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal 2:re1
11. Jinnin M, Medici D, Park L, Limaye N, Liu Y, Boscolo E, Bischoff J, Vikkula M, Boye E, Olsen BR 2008 Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14:1236-1246
12. Johnson DG, Schwarz JK, Cress WD, Nevins JR 1993 Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 365:349-352
13. Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G 2001 The E2F1-3 transcription factors are essential for cellular proliferation. Nature 414:457-462
14. Zhong TP, Childs S, Leu JP, Fishman MC 2001 Gridlock signaling pathway fashions the first embryonic artery. Nature 414:216-220
15. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T 2000 Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14:1343-1352
16. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, CamposOrtega JA, Weinstein BM 2001 Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128:3675-3683
17. Lawson ND, Vogel AM, Weinstein BM 2002 A sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 3:127-136
18. Weinstein BM, Lawson ND 2002 Arteries, veins, Notch, and VEGF. Cold Spring Harb Symp Quant Biol 67:155-162
19. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, Rand EB, Weinmaster G, Gridley T 1999 Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 8:723-730
20. Hrabeč de Angelis M, McIntyre II J, Gossler A 1997 Maintenance of somite borders in mice requires the Delta homologue DII1. Nature 386:717-721
21. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M 2004 The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-911
22. Seo S, Fujita H, Nakano A, Kang M, Duarte A, Kume T 2006 The forkhead transcription factors, Foxc1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev Biol 294:458-470
23. Hayashi H, Kume T 2008 Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS One 3:e2401
24. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY 2005 Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435:98-104
25. DeGregori J, Kowalik T, Nevins JR 1995 Cellular targets for activation by the E2F1 transcription factor include DNA synthesisand G1/S-regulatory genes. Mol Cell Biol 15:4215-4224
26. Ohtani K, DeGregori J, Nevins JR 1995 Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci USA 92: 12146-12150
27. Ohtani K, Tsujimoto A, Ikeda M, Nakamura M 1998 Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene 17:1777-1785
28. Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, Helin K 1999 CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 19:6379-6395
29. Kim BJ, Takamoto N, Yan J, Tsai SY, Tsai MJ 2009 Chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) regulates growth and patterning of the postnatal mouse cerebellum. Dev Biol 326:378-391
30. Pipaón C, Tsai SY, Tsai MJ 1999 COUP-TF upregulates NGFI-A gene expression through an Sp1 binding site. Mol Cell Biol 19: 2734-2745
31. Rohr O, Aunis D, Schaeffer E 1997 COUP-TF and Sp1 interact and cooperate in the transcriptional activation of the human immuno-deficiency virus type 1 long terminal repeat in human microglial cells. J Biol Chem 272:31149-31155
32. Lin FJ, Chen X, Qin J, Hong YK, Tsai MJ, Tsai SY 2010 Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 120:1694-1707
33. Johnson DG, Ohtani K, Nevins JR 1994 Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 8:1514-1525
34. Fortini ME 2002 β-Secretase-mediated proteolysis in cell-surface receptor signalling. Nat Rev Mol Cell Biol 3:673-684
35. Mumm JS, Kopan R 2000 Notch signaling: from the outside in. Dev Biol 228:151-165
36. Bray SJ 2006 Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7:678-689
37. Tsai SY, Tsai MJ 1997 Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr Rev 18:229-240
38. Kokubo H, Miyagawa-Tomita S, Johnson RL 2005 Hesr, a mediator of the Notch signaling, functions in heart and vessel development. Trends Cardiovasc Med 15:190-194
39. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T 2004 Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 18:2469-2473
40. Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J 2004 Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 18:2474-2478
41. Koo BK, Lim HS, Song R, Yoon MJ, Yoon KJ, Moon JS, Kim YW, Kwon MC, Yoo KW, Kong MP, Lee J, Chitnis AB, Kim CH, Kong YY 2005 Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. Development 132:3459-3470
42. Lin FJ, Tsai MJ, Tsai SY 2007 Artery and vein formation: a tug of war between different forces. EMBO Rep 8:920-924
43. Hong CC, Peterson QP, Hong JY, Peterson RT 2006 Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol 16:1366-1372
44. Ng YS, Krilleke D, Shima DT 2006 VEGF function in vascular pathogenesis. Exp Cell Res 312:527-537
45. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H 1999 A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895-4902
46. Huppert SS, Le A, Schroeter EH, Mumm JS, Saxena MT, Milner LA, Kopan R 2000 Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1. Nature 405:966-970
47. Jiang SX, Sheldrick M, Desbois A, Slinn J, Hou ST 2007 Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo. Mol Cell Biol 27: 1696-1705
48. Iso T, Kedes L, Hamamori Y 2003 HES and HERP families: multiple effectors of the Notch signaling pathway. J Cell Physiol 194: 237-255
49. Zhong TP, Rosenberg M, Mohideen MA, Weinstein B, Fishman MC 2000 Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science 287:1820-1824